Burning Rock Biotech Ltd - BNR

Sector: Healthcare · Industry: Diagnostics & Research
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$14.99M
QoQ value delta ($000)
-$12.35M (-45.18%)
Implied price effect (QoQ)
-46.56%
Shares
Total shares
1,754,402
QoQ shares delta
+44,046 (+2.58%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (BNR)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 17 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
Kynam Capital Management, LP 10,517 1,238,563 0.58%
CRCM LP 1,774 211,997 1.17%
RENAISSANCE TECHNOLOGIES LLC 442 52,838 0.0%
MORGAN STANLEY 364 43,594 0.0%
Redwood Wealth Management Group, LLC 294 18,278 0.13%
Amova Asset Management Americas, Inc. 257 29,724 0.0%
Sumitomo Mitsui Trust Group, Inc. 248 29,724 0.0%
BANK OF AMERICA CORP /DE/ 244 29,164 0.0%
CITADEL ADVISORS LLC 236 27,288 0.0%
HSG Holding Ltd 177 21,212 0.01%
UBS Group AG 149 17,916 0.0%
Almanack Investment Partners, LLC. 135 16,198 0.02%
XTX Topco Ltd 118 13,621 0.0%
BNP PARIBAS FINANCIAL MARKETS 23 2,800 0.0%
Tower Research Capital LLC (TRC) 10 1,242 0.0%
JPMORGAN CHASE & CO 1 166 0.0%
ROYAL BANK OF CANADA 1 73 0.0%
BlackRock, Inc. 0 4 0.0%